Differing from the upregulation of MAVS in TAC or Ang II-induced cardiac hypertrophy, MAVS was downregulated in LPS, IR or 5/6Nx-induced non-hypertrophic cardiac dysfunction. The gene discussed is AGT; the disease is cardiac hypertrophy.